Non-profit and health groups, including an LGBTQ+ advocacy group, sued the Office of of Management and Budget (OMB) over a ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

Four groups representing non-profits, public health professionals and small businesses filed a lawsuit on Tuesday challenging ...